[Home ] [Archive]    
:: Current Issue :: Search :: Submit an Article ::
:: Volume 14, Issue 1 (2022) ::
Iran J War Public Health 2022, 14(1): 25-35 Back to browse issues page
Utility of Some Fibrinolytic System Parameters for Differential Diagnosis Between Ischemic and Non-Cardiogenic Chest Pain
Y. Tyravska *1, O. Savchenko2, N. Altunina2, V. Lizogub2, O. Savchuk3
1- Department of Internal Medicine No. 4, Bogomolets National Medical University, 01601, Kyiv, Ukraine , yu-tyravska8773@uohk.com.cn
2- Department of Internal Medicine No. 4, Bogomolets National Medical University, 01601, Kyiv, Ukraine
3- Department of Biochemistry, Taras Shevchenko National University of Kyiv, 01601, Kyiv, Ukraine
Abstract:   (278 Views)
Aims: The study aimed to assess the diagnostic accuracy of some fibrinolytic parameters in the differential diagnosis between patients with unstable angina and musculoskeletal disorders.
Materials & Methods: This cross-sectional study included 119 patients with chest pain, and the provisional diagnosis “UA” was conducted in in 2021 in Bogomolets National Medical University. After a full set of diagnostic procedures, the authors formed four groups: patients with ischemic and non-cardiogenic chest pain without coronary artery disease history (1 & 2) or coronary artery disease history (3 & 4). Blood plasma tissue plasminogen activator and plasminogen activator inhibitor type 1 concentrations, tissue plasminogen activator/plasminogen activator inhibitor type 1, and plasminogen activator inhibitor type 1/tissue plasminogen activator ratios were analyzed.
Findings: Binary logistic models were assessed, receiver operating characteristic curves, calculated sensitivity, specificity, and positive likelihood ratio of each indicator. No diagnostic utility of tissue plasminogen activator concentration alone was revealed (p=0.68). Plasminogen activator inhibitor type 1 concentration and plasminogen activator inhibitor type 1/tissue plasminogen activator ratio demonstrated a moderate increase (by 28% and 26%) in the probability of UA (positive likelihood ratio= 4.66 (2.57, 8.45) and 3.87 (2.29, 6.55), sensitivity 87.3% and 88.7%, specificity 81.2% and 77.1% at cut-off point 0.343rel.units/ml and 1.775, respectively), while tissue plasminogen activator/plasminogen activator inhibitor type 1 raised the probability of MSD by 41% (positive likelihood ratio= 6.47 (3.29, 13.00), sensitivity 72.9%, specificity 88.7% at cut-off point 0.584).
Conclusion: PAI-1 concentration alone and tissue plasminogen activator /PAI-1 ratio but not tissue plasminogen activator alone have demonstrated promising results for differential diagnostic between ischemic and non-cardiogenic chest pain.
Keywords: |chest pain|fibrinolytic system|musculoskeletal disorders|plasminogen activator inhibitor|unstable angina ,
Full-Text [PDF 663 kb]   (214 Downloads)    
Article Type: Original Research | Subject: Diagnosis and Treatment of Veterans or Handicapped Diseases
Received: 2022/01/5 | Accepted: 2022/02/23 | Published: 2022/01/20
* Corresponding Author Address: 13 Shevchenko Blvd., Kyiv, Ukraine. Postal Code: 01601
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tyravska Y, Savchenko O, Altunina N, Lizogub V, Savchuk O. Utility of Some Fibrinolytic System Parameters for Differential Diagnosis Between Ischemic and Non-Cardiogenic Chest Pain. Iran J War Public Health. 2022; 14 (1) :25-35
URL: http://ijwph.ir/article-1-1110-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 14, Issue 1 (2022) Back to browse issues page
مجله طب جانباز Iranian Journal of War and Public Health
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 4410